Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 34 (2) , 227-236
- https://doi.org/10.1016/0090-1229(85)90027-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpuraBlood, 1983
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA: Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells?The Lancet, 1983
- Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP)Annals of Hematology, 1983
- Binding of C3b proceeds by a transesterification reaction at the thiolester siteNature, 1982
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982
- Complement‐fixing platelet autoantibodies in autoimmune thrombocytopeniaAmerican Journal of Hematology, 1981
- Fixation of C3 to Platelets in Vitro by Antiplatelet Antibody from Patients with Immune Thrombocytopenic PurpuraBritish Journal of Haematology, 1981
- Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.The Journal of Experimental Medicine, 1980
- Immune ThrombocytopeniaNew England Journal of Medicine, 1979
- Platelet-bound complement (C3) in immune thrombocytopeniaBlood, 1977